Soluble CD30 in normal pregnancy pre-eclampsia and recurrent pregnancy loss

Iranian Journal of Immunology

Volumn 9, Issue 4, 2012, Pages 234-240

  Gharesi Fard, Behrouz ^a,b   Jafarzadeh, Leila ^b   Zolghadri, Jaleh ^a,b   Haghbin, Hossein ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Pre Eclampsia; Recurrent Abortion; SCD30

Indexed keywords

CD30 ANTIGEN;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; RECURRENT ABORTION; SECOND TRIMESTER PREGNANCY; STUDENT T TEST; TH2 CELL; THIRD TRIMESTER PREGNANCY;

ABORTION, HABITUAL; ADULT; ANTIGENS, CD30; FEMALE; GESTATIONAL AGE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS; TH1-TH2 BALANCE; TH2 CELLS; YOUNG ADULT;

EID: 84872706186     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Practice Committee of the American Society for Reproductive Medicine. Difinitions of infertility and recurrent pregnancy loss. Fertil Steril. 2008; 90:S60.
2. Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996; 66:24-9.
3. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011; 7: 467-74.
4. Turner JA. Severe Preeclampsia: Anesthetic Implications of the Disease and its Management. Am J Ther. 2009; 16:284-8.
5. Pandey MK, Rani R, Agrawel S. An update in recurrent spontaneous abortion. Arch Gynecol Obstet. 2005; 271:95-108.
6. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med. 2007; 28:192-209.
7. van Mourik MS, Macklon NS, Heijnen CJ. Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J Leukoc Biol. 2009; 85:4-19.
8. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986; 136:2348-57.
9. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today. 1997; 18:478-82.
10. Saini V, Arora S, Yadav A, Bhattacharjee J. Cytokine in recurrent pregnancy loss. Clin Chim Acta. 2011; 412:702-8.
11. Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol. 2003; 59:161-73.
12. Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell. 1993; 73:1349-60.
13. Hansen HP, Kisseleva T, Kobarg J, Horn-Lohrens O, Havsteen B, Lemke H. A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines. Int J Cancer. 1995; 63:750-6.
14. Romagnani S, Del Prere G, Maggi E, Chilosi M, Caligaris-Cappio F, Pizzolo G. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol. 1995; 57:726-30.
15. Hoshimoto K, Ohta N, Ohkura T, Inaba N. Changes in plasma soluble CD26 and CD30 during pregnancy:markers of Th1/Th2 balance? Gynecol Obstet Invest. 2000; 50:260-3.
16. Kusanovic JP, Romero R, Hassan SS, Gotsch F, Edwin S, Chaiworapongsa T, et al. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies. J Matern Fetal Neonatal Med. 2007; 20:867-78.
17. Laskowska M, Laskowska K, Oleszczuk J. Soluble CD30 in normotensive pregnant women with isolated fetal intrauterine growth restriction: a comparison with preeclamptic women. J Reprod Immunol. 2010; 86:122-5.
18. Kusanovic JP, Romero R, Esoinoza J, Gotsch F, Edwin S, Chaiworapongsa T, et al. Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis. J Matern Fetal Neonatal Med. 2007; 20:803-11.
19. Laskowska M, Laskowska K, Oleszczuk J. Evaluation of sCD30 level in maternal serum in pregnancies complicated by severe preeclampsia. Med Wieku Rozwoj. 2011; 15:73-8.
20. Makhseed M, Raghupathy R, Azizieh F, Farhat R, Hassan N, Bandar A. Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions. Hum Reprod. 2000; 15: 2011-7.
21. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol. 1996; 106:127-33.
22. Saito S, Umekage H, Sakamoto Y, Sakai M, Tanabe K, Sasaki Y, et al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol. 1999; 41:297-306.
23. Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod. 2000; 15:713-8.
24. Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol. 1999; 117:550-5.
25. Makhseed M, Raghupathy R, Azizieh F, Omu A, Al-Shamali E, Ashkanani L. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod. 2001; 16:2219-26.
26. Szarka A, Rigó J Jr, Lázár L, Beko G, Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010; 11:59.
27. Molvarec A, Szarka A, Walentin S, Beko G, Karádi I, Prohászka Z, et al. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol. 2011; 9:124.
28. Molvarec A, Shiozaki A, Ito M, Toldi G, Stenczer B, Szarka A, et al. Increased prevalence of peripheral blood granulysinproducing cytotoxic T lymphocytes in preeclampsia. J Reprod Immunol. 2011; 91:56-63.
29. Chaouat G, Lédée-Bataille N, Zourbas S, Ostojic S, Dubanchet S, Martal J, et al. Cytokines, implantation and early abortion: re-examining the Th1/Th2 paradigm leads to question the single pathway, single therapy concept. Am J Reprod Immunol. 2003; 50:177-86.
30. Peck A, Mellins ED. Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology. 2010; 129:147-53.
31. Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol. 2010; 159:109-19.
32. Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005; 6:345-52.
33. Toldi G, Rigó J Jr, Stenczer B, Vásárhelyi B, Molvarec A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am J Reprod Immunol. 2011; 66:223-9.
34. Toldi G, Saito S, Shima T, Halmos A, Veresh Z, Vásárhelyi B, et al. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25-FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia. Am J Reprod Immunol. 2012; 68:175-80.
35. NakashimaA, Ito M, Shima T, BacN D, Hidaka T, Saito S. Accumulationof IL-17-positive cells in decidua of inevitable abortion cases. Am J Reprod Immunol. 2010; 64:4-11.
36. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol. 2012; 93:75-81.
37. Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is associated with reduced expression of the Tregulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod. 2006; 12:301